Sheila Jacobs

All articles by Sheila Jacobs

• The role of platelets in FNAIT, explained

  Learn more about the role of platelets in FNAIT, including how they contribute to development and treatment.

• Investigational drug shows early promise in preventing FNAIT

  An investigational drug developed by Rallybio to prevent FNAIT produced positive results in a phase 1 clinical trial.

• Analysis calls for more data on platelet transfusion refractoriness

  A recent analysis highlighted the need for additional data on the causes and mechanisms of platelet transfusion refractoriness.

• A guide to FNAIT treatment and management during pregnancy

  Learn about how the different methods a medical care team may use to manage and treat FNAIT during pregnancy.

• Study will compare nipocalimab vs IVIG in those at risk of FNAIT

  A new study to compare treatment with nipocalimab versus IVIG in pregnant people at risk of FNAIT will be enrolling patients soon.

• Blood donor registry aids in FNAIT treatment in Greece

  A new registry of human platelet antigen (HPA)–typed blood donors may help treat fetal and neonatal alloimmune thrombocytopenia (FNAIT) in Greece.

• Genotyping in infants with thrombocytopenia could rule out FNAIT

  A case report described a wrongful diagnosis of FNAIT that could have been prevented if HPA genotyping had been performed sooner.

• Mothers report negative effects of FNAIT on emotional, physical health

  According to a recent poster presentation, women with FNAIT reported negative effects on their emotional and physical health.

• Study shows FNAIT-affected mothers need more support

  In a recent study, mothers affected by FNAIT reported their diagnosis had a significant negative effect on their well-being.

• FDA fast tracks J&J’s nipocalimab to reduce risk of FNAIT

  Johnson & Johnson has announced the FDA’s fast track approval of nipocalimab for treating FNAIT in alloimmunized pregnant persons.